HUM vs STOK · P/E 39, rev $117.76B vs rev $36.6M
Humana Inc (HUM) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. STOK currently screens at market cap $1.88B.
Not investment advice. Open the HUM and STOK stock pages for the full models.
Not investment advice.